ReviewBiomedicines2023

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.

Francesco Lasorsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.